Tech Company Financing Transactions
Innovative Biologics Funding Round
Innovative Biologics, operating out of Herndon, secured $100 thousand from CIT GAP Fund.
Transaction Overview
Company Name
Announced On
3/31/2008
Transaction Type
Venture Equity
Amount
$100,000
Round
Undisclosed
Investors
CIT GAP Fund (Peter Jobse)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
13455 Sunrise Valley Dr. 200
Herndon, VA 20171
USA
Herndon, VA 20171
USA
Phone
Website
Email Address
Overview
Innovative Biologics is an anti-infective drug discovery and development company targeting microbes that produce pore-forming toxins.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
C.W. Gilluly
Chief Executive Officer
Jeff Conroy
Chief Scientific Officer
Vladimir Karginov
Browse more venture capital transactions:
Prev: 3/31/2008: CaloSyn Pharma venture capital transaction
Next: 3/31/2008: mindSHIFT Technologies venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs